Flu cases have more than doubled from last year in Windsor-Essex
Calling it a "significant increase" across the region, officials are reminding the public that respiratory illness season is ongoing and asking people to protect themselves.
In a statement, WECHU said local hospitals are seeing a rise in people with the same respiratory symptoms — but that non-emergency concerns shouldn't be directed to emergency departments.
Calling it a 'significant increase across Windsor-Essex, officials are reminding residents that respiratory illness season is ongoing and are asking for people to protect themselves. (CBC)
According to the health unit, getting vaccinated for the flu, COVID-19 and respiratory syncytial virus (RSV) are the "best ways to prevent serious illness and avoid hospital visits."
"At Erie Shores HealthCare, we have taken proactive steps to manage the increased demand for care, including expanding our capacity by utilizing unconventional treatment spaces, utilizing the Mobile Medical Clinic on-site, and ensuring our health-care teams are equipped to respond efficiently," said CEO Kristin Kennedy.
Hôtel-Dieu Grace Healthcare in Windsor says it's opened an additional 25 beds since last fall to help deal with the influx of people coming into their care with flu-like symptoms.
"I encourage everyone to practise good hygiene, consider wearing a mask while at the hospital, stay home if you are sick and try to limit the number of visitors if you or a family member is hospitalized," said HDGH president Bill Marra.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
26 minutes ago
- Business Wire
Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union
WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, announced today that it has filed suit in the Unified Patent Court (UPC) of the European Union against Pfizer Inc. and certain of its subsidiaries (action number 35071/2025), seeking a determination of liability for use and infringement of European Patent No. EP 4 051 265 (the '265 Patent) in the manufacture, use and sale of Pfizer's COVID-19 antiviral, Paxlovid™ (nirmatrelvir tablets; ritonavir tablets). This enforcement action targets Pfizer's activities in the 18 countries of the European Union that are presently participating in the UPC. The European Patent Office's recent grant of the '265 Patent to Enanta was published in the European Patent Bulletin today. The '265 Patent is based on Enanta's July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists. The '265 Patent is the European counterpart of U.S. Patent No. 11,358,953 (the '953 Patent) involved in ongoing U.S. litigation between Enanta and Pfizer Inc. Under UPC procedures, a hearing on the infringement action is expected to occur within the UPC's published 12-month target, with the decision rendered within weeks thereafter. If the UPC determines there has been infringement, subsequent proceedings would be required to determine damages. All timelines remain subject to potential rights of appeal and other customary proceedings in European patent litigation. About Enanta Pharmaceuticals, Inc. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta's clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing hepatitis C virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET ® (U.S.) and MAVIRET ® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta's royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta's operations. Please visit for more information. Forward Looking Statements Disclaimer This press release contains forward-looking statements, including statements with respect to Enanta's filing in the UPC of a suit against Pfizer Inc. and certain of its subsidiaries seeking a determination of liability for use and infringement of Enanta's patent and Enanta's expectations with respect to any further action with respect to such proceedings. Statements that are not historical facts are based on management's current expectations, estimates, forecasts and projections about Enanta's business and the industry in which it operates and management's beliefs and assumptions. The statements contained in this release are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed in such forward-looking statements. Important factors and risks that may affect actual results include: Enanta is competing to develop intellectual property in areas of small-molecule drug development that are highly competitive; issued patents, including those covering one or more of its product candidates, could be found invalid or unenforceable if challenged in court and could be costly to defend and be a distraction for Enanta's senior management and scientific personnel; intellectual property litigation may lead to unfavorable publicity that harms Enanta's reputation and causes the market price of its common stock to decline; and other risk factors described or referred to in 'Risk Factors' in Enanta's Form 10-K for the fiscal year ended September 30, 2024 and other periodic reports filed more recently with the Securities and Exchange Commission. Enanta cautions investors not to place undue reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this release, and Enanta undertakes no obligation to update or revise these statements, except as may be required by law.
Axios
an hour ago
- Axios
Doctors mount vaccine safety review to rival feds'
An ad-hoc group of infectious disease doctors and health researchers on Tuesday held a public meeting to review recent studies on the safety and effectiveness of COVID, RSV and flu vaccines, in the belief the data isn't being adequately considered by federal health officials. Why it matters: The unusual online gathering of the newly formed Vaccine Integrity Project was intended to provide an evidence base for doctors and public health officials as they update recommendations for kids, pregnant women and immunocompromised people. The agenda resembled those of a vaccine advisory board to the Centers for Disease Control and Prevention that's come under scrutiny since Health Secretary Robert F. Kennedy Jr. purged its 17 members and replaced them with a handpicked roster that includes some known vaccine skeptics. What they're saying:"Over the last few months, we've seen policy changes by federal officials based on evidence that has been shown as flawed, analytically fraught, or flat-out wrong," said Michael Osterholm, an epidemiologist at the University of Minnesota and a leader of the initiative. "It's vital that providers and the public continue to have vaccine information they can rely on," he said during the meeting. HHS didn't respond to a request for comment. What they did: The group of 24 doctors and researchers from across the countryexamined scientific studies published since mid-2024 for COVID and RSV vaccines, and mid-2023 for flu. The group reviewed more than 14,000 peer-reviewed scientific articles and extracted data from 590 studies, including 50 controlled trials, Osterholm said. The effort is being funded by Alumbra, a foundation established by philanthropist and Walmart heiress Christy Walton. The panel found that recent research shows flu, COVID and RSV vaccines remain safe and effective for kids, pregnant women and immunocompromised people. Data continued to show a possible increased risk of preterm birth associated with Pfizer's RSV vaccine. Osterholm said there is no scientific evidence to justify Kennedy's recent decision to no longer recommend COVID vaccines for healthy pregnant women or children. Zoom out: The American Academy of Pediatrics on Tuesday separately released its immunization guidelines for flu, RSV and COVID-19 ahead of the fall respiratory virus season. For the first time, the group's guidelines diverge from the federal government's. The pediatricians recommend COVID vaccines for all kids between six and 23 months old, and for kids over 2 years old at risk for severe disease. The Trump administration earlier this year said it would require new randomized clinical trials for COVID boosters before authorizing them for healthy individuals. The American College for Obstetricians and Gynecologists earlier said it would release its own guidelines for respiratory virus vaccines during pregnancy in coordination with the Vaccine Integrity Project. Reality check: Advisory Committee on Immunization Practices vaccine recommendations that get approved by the CDC must be covered by health insurers. That's not the case for vaccine recommendations from medical associations.
NBC News
an hour ago
- NBC News
Doctors say medical misinformation has gotten worse, survey finds
A survey of doctors released Wednesday showed how pervasive medical falsehoods have become — not only online, but also within the walls of medical exam rooms where doctors and patients talk. The survey from the Physicians Foundation, a nonprofit research group, found that 61% of doctors said they encountered patients influenced by misinformation or disinformation a moderate amount or a great deal of the time over the past year. An overwhelming majority of physicians, 86%, said the incidence of such falsehoods among patients had increased over the past five years, a period that includes most of the Covid pandemic, with 50% saying it had increased significantly. The survey is a rare look into how often doctors encounter pseudoscience in their everyday practice of medicine, and it indicates how their jobs are changing in response to a new information environment in which distorted health claims spread easily online and sometimes have the backing of government authorities. Dr. Gary Price, president of the Physicians Foundation, said the organization set out to conduct the survey because it knew doctors were frustrated by medical falsehoods and wanted to find out the extent of the problem. 'It's frustrating. It's demoralizing,' he said in a phone interview. 'It cuts to the core of what motivates most physicians, and that's a desire to help people in the most fundamental of ways. And in a way, it's a repudiation of all the different things that lead people to practice medicine.' A majority of doctors in the survey, 57%, said they believed misinformation and disinformation had at least a moderate impact on their ability to provide quality care to patients. Price, a plastic surgeon, said medical falsehoods are making physicians' jobs harder or, in some cases, impossible. He said one of his patients decided to cancel an operation during the Covid pandemic because the patient refused to take a Covid test, not believing the virus was dangerous. 'Even though you feel personally responsible for your patient's health and, in many ways, the system holds you responsible for it, you no longer have any reasonable control over the outcome,' he said. For doctors, he added, 'that's a setup for burnout.' False health claims are widespread, especially on the internet, and they affect a wide array of subjects, from vaccines to dietary supplements. The survey did not ask about specific types of misinformation, but its respondents were a cross-section of the profession: primary care physicians and specialists, early-career doctors and more experienced ones, and doctors in urban, suburban and rural areas. The online survey of 1,002 physicians was conducted in May. The survey arrives when misinformation appears to be on the upswing, both online and in the federal government. Health and Human Services Secretary Robert F. Kennedy Jr., who has a history of making false or misleading claims about vaccines and other topics, has continued to attack medical research and worry infectious disease experts with his actions and rhetoric since he took office. Anti-vaccine myths surged on social media ahead of this month's shooting at the Centers for Disease Control and Prevention headquarters in Atlanta. The gunman blamed a Covid vaccine for his mental health issues, including depression, despite no clear evidence showing a link. Price said Kennedy and others in authority have a duty to be accurate. 'Public health officials, elected or not, have a fundamental obligation to make sure that the public gets information that's accurate and that can be trusted and ... to continue to ensure that the entire system can be trusted,' he said. A representative for Kennedy did not immediately respond to a request for comment Tuesday, ahead of the survey's release. Dr. Seema Yasmin, a clinical assistant professor of medicine at Stanford University who was not involved in the survey, said the results show the very difficult position that medical professionals are in. 'It's too much to expect a physician or nurse practitioner, for example, to address complex, deep-seated beliefs in an eight-to-twelve minute consult,' she said in an email. 'Healthcare workers are on the frontlines, they are hearing pseudoscientific statements day in and day out, and it takes great effort to correct these and to provide accurate information to patients, while maintaining relationships in which patients can share things they've heard or that they believe,' she said. Yasmin, author of ' What the Fact?,' a book about media literacy and conspiracy theories, said further research could look at how many physicians admit to having fallen for false information themselves. 'Sadly, sometimes our colleagues fall for the falsehoods, too,' she said. 'We need to be aware of our own vulnerabilities.' The Physicians Foundation was founded in 2003 with proceeds from a class action settlement, in which doctors sued health insurance companies over billing practices. It provides grants to universities, hospitals and other institutions for medical research and to address physician well-being. At least one other survey of physicians has shown similar results. In a 2023 survey by the de Beaumont Foundation, a public health organization, 72% of physicians said misinformation had made it harder to treat patients for Covid, and the same share said it had negatively affected outcomes. Other surveys have shown that misinformation spreads widely among the public. In an April poll, the nonprofit health policy foundation KFF found that 63% of U.S. adults had read about or heard about the false myth that the measles vaccine causes autism. Price said he would like to see more physicians turn to social media as part of their jobs to counter medical misinformation on the platforms where it often spreads. 'The medical profession needs to get into that channel of communications, but not just by posting studies there,' he said. 'We need to learn how to communicate better in that medium. We're just way behind. And I think the way I think about it, we need to be just as rigorous about examining the best way to do that as we are at trying to figure out the best ways to do an operation or develop a new medication.'
